Chandrasekhar Cherukupalli, MD
Vascular Surgery · Evansville, INNPI 1942406673
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 68.0% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $9,089, 6.4 times the $1,428 reported in 2019.
Across 105 payments — averaging $182.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$13K
- Penumbra, Inc.$2K
- Zimmer Biomet$1K
- Bard Peripheral Vascular, Inc.$1K
- Johnson & Johnson$499
- Silk Road Medical, Inc.$377
- plus $1K from 19 others
What the payments were for
- Consulting fees$9,53850%
- Travel & lodging$5,89231%
- Food & beverage$3,70619%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $13,029 |
| Penumbra, Inc. | 5 | $1,627 |
| Zimmer Biomet | 13 | $1,195 |
| Bard Peripheral Vascular, Inc. | 5 | $1,193 |
| Johnson & Johnson(2 entities) | 19 | $499 |
| Silk Road Medical, Inc. | 5 | $377 |
| EKOS Corporation | 2 | $165 |
| Abbott | 7 | $144 |
| Surmodics, Inc. | 2 | $137 |
| Bayer | 1 | $128 |
| Medtronic | 5 | $114 |
| W. L. Gore & Associates, Inc. | 2 | $107 |
| Stryker | 2 | $88 |
| Inari Medical, Inc. | 2 | $53 |
| Endologix LLC | 2 | $46 |
| TELA Bio, Inc. | 1 | $43 |
| Polynovo North America LLC | 2 | $40 |
| Kerecis Limited | 1 | $35 |
| Lemaitre Vascular, Inc. | 1 | $29 |
| Innovation Technologies Inc | 1 | $23 |
| Angiodynamics, Inc. | 1 | $21 |
| Argon Medical Devices, Inc. | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $21 |
| Ambu Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$6,948
- Indigo System$1,480
- AdvantageRib$666
- ENROUTE Transcarotid Neuroprotection System$250
- Indigo$249
- ENROUTE Transcarotid Stent$143
- EKOSONIC$140
- Kerendia$128
- ENROUTE Transcarotid Stent System$108
- ENHANCE Transcarotid Peripheral Access Kit$108
- ENROUTE 0.014 Guidewire$108
- Sublime 014 Rx PTA Balloon Dilatation Catheter$106
- Sublime Microcatheter, 018, 200cm, Straight$106
- Pounce Thrombectomy System$106
- Pounce Thrombectomy$106
- Pounce Venous Thrombectomy System$106
How this compares
$19,173 in reported general payments places this provider in the 85th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $20,550 |
| ClopidogrelClopidogrel Bisulfate | 269 | $2,231 |
| Cilostazol | 28 | $377 |
| Famotidine | 14 | $162 |
| Methylprednisolone | 13 | $85 |
| Tramadol Hcl | 41 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $499 | $20,55018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Evansville
- Angela MartinEvansville$54K
- Matthew LangenbergEvansville$36K
- Donald PattersonEvansville$11K
- Prasad GadeEvansville$9K
- Michael ShaoFort Wayne$155K
- Sajjad HussainIndianapolis$109K
- Ricardo VasquezBloomington$82K
- Andres FajardoIndianapolis$58K
- Luis GomezMishawaka$52K
- Brandon DowningIndianapolis$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.